AlphaMadera's AlphaVal page computes Parker-Hannifin Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag PH as undervalued, fairly valued, or overvalued.

What is Parker-Hannifin Corporation's fair value?

Fair value for PH is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value PH?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from PH's most recent reported fundamentals.

PH - Parker-Hannifin Corporation

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $1,047.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Moderate

Trading 15.6% above fair value

Current Price $866.96

Bear Case $478.43 44.8% downside ($478.43 - $866.96) / $866.96 = -44.8% 8% stage 1 growth, 11% discount

Fair Value $749.78 13.5% downside ($749.78 - $866.96) / $866.96 = -13.5% 13% stage 1 growth, 11% discount

Bull Case $1,038.14 19.7% upside ($1,038.14 - $866.96) / $866.96 = 19.7% 17% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

13.1%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (13% base case)

Terminal Value % of EV 41%

Implied Market Multiple 36.8x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $1047.00 from 38 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $749.78 per share.

Warnings

ℹ Wall Street's average price target is $1047.00 (from 38 analysts). Our estimate is 41% below the consensus -- consider that gap carefully.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions